Takeda Pharmaceutical Co ADR (NYSE:TAK) shares, rose in value, with the stock price down by -2.46% to the previous day’s close as strong demand from buyers drove the stock to $14.76.
Actively observing the price movement in the recent trading, the stock is buoying the session at $15.13, falling within a range of $14.755 and $14.88. The value of beta (5-year monthly) is 0.26 whereas the PE ratio is 67.91 over 12-month period. Referring to stock’s 52-week performance, its high was $15.53, and the low was $12.80. On the whole, TAK has fluctuated by -1.95% over the past month.
With the market capitalization of Takeda Pharmaceutical Co ADR currently standing at about $46.45 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08. The company’s Forward Dividend Ratio is 0.33, with its dividend yield at 2.21%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TAK’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.43, with the price of TAK currently trading nearly -2.23% and -0.69% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.17, while the 7-day volatility ratio is showing 0.92% which for the 30-day chart, stands at 1.01%. Furthermore, Takeda Pharmaceutical Co ADR (TAK)’s beta value is 0.27.
A comparison of Takeda Pharmaceutical Co ADR (TAK) with its peers suggests the former has fared considerably weaker in the market. TAK showed an intraday change of -2.46% in today’s session so far, and over the past year, it grew by 11.46%%.
Data on historical trading for Takeda Pharmaceutical Co ADR (NYSE:TAK) indicates that the trading volumes over the past 10 days have averaged 2.07 and over the past 3 months, they’ve averaged 2.09 million. According to company’s latest data on outstanding shares, there are 3.15 billion shares outstanding.
Nearly 0.02% of Takeda Pharmaceutical Co ADR’s shares belong to company insiders and institutional investors own 5.05% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.5 million shares as on 2025-06-13, resulting in a short ratio of 3.42. According to the data, the short interest in Takeda Pharmaceutical Co ADR (TAK) stood at 21.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 6.24 million. The stock has risen by 11.97% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TAK stock heading into the next quarter.
